NHS National Generic Pharmaceuticals Interim 2
key details
| Value | £18,767,757 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33690000 |
| Deadline | 5 Oct 2020 |
| Contract start | 1 Feb 2021 |
| Contract end | 28 Feb 2022 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-fb12a8e2-17d3-49d5-bb3b-a982582d6e51 |
Awards (51)
This procurement was awarded to 51 suppliers. Values shown are per-award; the notice total is £18,767,757.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Accord-UK Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Altan Pharma Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Amarox Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Aspire Pharma Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Aventis Pharma ltd t/a Sanofi shared | £12,327,097 | 21 Dec 2020 | active |
| Baxter Healthcare Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Bristol Laboratories Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Brown & Burk UK Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Cipla (EU) Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Consilient Health Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Crescent Pharma Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| CST Pharma Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Drugsrus Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Essential-Healthcare Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Focus Pharmaceuticals Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Fresenius Kabi Limited shared | £12,327,097 | 21 Dec 2020 | active |
| GlaxoSmithKline UK Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Healthcare Pharma Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| HFA Healthcare Products Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Kent Pharma Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Laboratorio Reig Jofre SA shared | £12,327,097 | 21 Dec 2020 | active |
| Lexon UK Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Macleods Pharma UK Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Manx Healthcare Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Martindale Pharma shared | £12,327,097 | 21 Dec 2020 | active |
| medac Pharma LLP shared | £12,327,097 | 21 Dec 2020 | active |
| Medley Pharma Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Medreich PLC shared | £12,327,097 | 21 Dec 2020 | active |
| Mercury Pharmaceuticals Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Milpharm Ltd/aurobinbdo shared | £12,327,097 | 21 Dec 2020 | active |
| Morningside Pharmaeuticals shared | £12,327,097 | 21 Dec 2020 | active |
| Mylan shared | £12,327,097 | 21 Dec 2020 | active |
| Necessity Supplies Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Panpharma UK Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Pfizer Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| QDEM PHARMACEUTICALS LIMITED shared | £12,327,097 | 21 Dec 2020 | active |
| Ranbaxy UK shared | £12,327,097 | 21 Dec 2020 | active |
| Rivopharm UK Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Sandoz Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Sciecure Pharma Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Selective Supplies Ltd. shared | £12,327,097 | 21 Dec 2020 | active |
| Syri Limited (T/A Thame Laboratories) shared | £12,327,097 | 21 Dec 2020 | active |
| Teva UK Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Thornton and Ross Ltd shared | £12,327,097 | 21 Dec 2020 | active |
| Tillomed Laboratories ltd shared | £12,327,097 | 21 Dec 2020 | active |
| UpJohn Limited UK shared | £12,327,097 | 21 Dec 2020 | active |
| Waymade PLC shared | £12,327,097 | 21 Dec 2020 | active |
| Wockhardt UK Limited shared | £12,327,097 | 21 Dec 2020 | active |
| Zentiva Pharma UK Ltd shared | £12,327,097 | 21 Dec 2020 | active |
description
NHS National Generic Pharmaceuticals Interim 2 2020
Offer reference number: CM/PHG/20/5619
Period of framework agreement: 12 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months Potential periods of call-offs under the framework agreement:
| Hospital only products - All regions: | 01/02/2021 to 31/01/2022 |
| Orals (plus non-parenterals) - All regions: | 01/03/2021 to 28/02/2022 |
documents
- https://www.contractsfinder.service.gov.uk/Notice/5cbccead-509c-48ed-9384-016dd54ef316 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 16 Feb 2021 | Tender cancelled (tenderCancellation) | · | 5cbccead-509c-48ed-9384-016dd54ef316-413581 |
| 16 Feb 2021 | Award (award) | · | c915f888-00fd-4d17-a50e-f9891d77f9fa-413594 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Labs Consumables ePunchout 3 · UNIVERSITY OF SOUTHAMPTON · £1,500,000
- Supply of reagents · NEWCASTLE UNIVERSITY · £177,420
- Supply of reagents · NEWCASTLE UNIVERSITY · £37,829
- Supply of reagents · NEWCASTLE UNIVERSITY · £36,485
- Supply of Antibodies · NEWCASTLE UNIVERSITY · £23,108
- Suplly of Reagents · NEWCASTLE UNIVERSITY · £23,212
- Controlled drugs · London Ambulance Service NHS Trust · £154,225
- IonOptix cardiomyocyte fluo-3 calcium and contractility acquisition system. · UNIVERSITY OF NOTTINGHAM (THE) · £67,737
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.